Combined Therapeutics
PrivateLast Round
Early Funding
Mar 8, 2023
Total Funding Raised
$500,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Combined Therapeutics is a biotechnology company that develops mRNA-based vaccines and therapeutics for infectious diseases and oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Combined Therapeutics Comparables
Compare Combined Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Strand Therapeutics | 81% | |
| aceRNA Technologies Co., Ltd. | 81% | |
| Kernal Biologics | 81% | |
Combined Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 8, 2023 | ||||
| Grant | Sep 25, 2020 | ||||
| Seed | Dec 12, 2017 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors grew 169% MoM, reaching 2.7K.
- Apr 2, 2026
Monthly visitors increased 64% MoM.
Combined Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Combined Therapeutics's valuation, stock price, and market status.